48
Perioperative pathophysiology and the objectives behind Enhanced Recovery Care Francesco Carli, MD, MPhil McGill University Montreal, Canada [email protected]

PERIOperative pathophysiology and the objectives behind

  • Upload
    others

  • View
    2

  • Download
    0

Embed Size (px)

Citation preview

Page 1: PERIOperative pathophysiology and the objectives behind

Perioperative pathophysiology and the objectives behind Enhanced Recovery

Care

Francesco Carli, MD, MPhil

McGill University

Montreal, Canada [email protected]

Page 2: PERIOperative pathophysiology and the objectives behind
Page 3: PERIOperative pathophysiology and the objectives behind

Ann Surg 2000

60 patients (74 yo) Open colon resection + postop care

program Epidural, early feeding and mobilization Median LOS 2 days 15% readmissions

Page 5: PERIOperative pathophysiology and the objectives behind

Surgical stress: pain, catabolism, fluid/salt

retention, immune dysfunction, nausea/vomiting,

ileus, impaired pulmonary function, increased cardiac

demands, hypercoaguability, sleep disturbances, fatigue

Kehlet and Wilmore, Ann Surg 2008 (revised)

Elements of the stress response

Page 6: PERIOperative pathophysiology and the objectives behind

Surgery is a stressor

Page 7: PERIOperative pathophysiology and the objectives behind
Page 8: PERIOperative pathophysiology and the objectives behind
Page 9: PERIOperative pathophysiology and the objectives behind

Surgical stress: pain, catabolism, fluid/salt

retention, immune dysfunction, nausea/vomiting,

ileus, impaired pulmonary function, increased cardiac

demands, hypercoaguability, sleep disturbances, fatigue

Kehlet and Wilmore, Ann Surg 2008 (revised)

Elements of the stress response mediated by insulin resistance

Page 10: PERIOperative pathophysiology and the objectives behind

Surgical stress: pain, catabolism, fluid/salt

retention, immune dysfunction, nausea/vomiting,

ileus, impaired pulmonary function, increased cardiac

demands, hypercoaguability, sleep disturbances, fatigue

Kehlet and Wilmore, Ann Surg 2008 (revised)

Approaches to reduce surgical stress

Minimally Invasive Surgery

Afferent neural blockade: local infiltration anesthesia

peripheral nerve blocks epidural/spinal anesthesia

Pharmacologic interventions: non-opioid, multimodal analgesia

anti-emetics glucocorticoids

systemic local anesthetics insulin

β-blockade α2-agonists

anabolic agents Nutrition

Other interventions: fluid balance

normothermia preoperative carbohydrate

postoperative nutrition

Page 11: PERIOperative pathophysiology and the objectives behind

ERAS

Epidural

Anaesthesia

Prevention

of ileus/

prokinetics

CHO - loading/

no fasting

Early

mobilisation

Peri-op fluid

management

DVT

prophylaxis

Pre-op Education

Remifentanyl

No - premed

No bowel prep

Perioperative

Nutrition

Normothermia

Oral analgesics/

NSAID’s

Incisions

No NG tubes

Early removal

of catheters/drains

Fearon et a al 2005, Lassen et al Arch Surg 2009

Page 12: PERIOperative pathophysiology and the objectives behind

3 days Hypocaloric nutrition* cause insulin resistance

Svanfeldt M et al, Clin Nutr 2003; 1: 31-38

(%change)

* 2000 ml 2.5% glucose

Page 13: PERIOperative pathophysiology and the objectives behind

Pain reduce Insulin sensitivity

Greisen et al, Anesthesiology 2001

Mg/k

g/m

in **

More

Insulin

Resistance

Page 14: PERIOperative pathophysiology and the objectives behind

Effect of bed rest

Biolo G et al, Am J Clin Nutr 2007, 86: 366-77

µmol x kg LBM-1 x min-1

Page 15: PERIOperative pathophysiology and the objectives behind

Combined hypocarolic feeding and bed rest increase protein catabolism

Biolo G et al, Am J Clin Nutr 2007, 86: 366-77

*P<0,04

*

Page 16: PERIOperative pathophysiology and the objectives behind

Metabolic changes

Day Night

Hormones Insulin + Insulin – Glucagon Cortisol

Substrates Storage Breakdown

Utilization CHO > Fat Fat > CHO

Page 17: PERIOperative pathophysiology and the objectives behind

Resistance is in uptake

0

1

2

3

4

5

6

7

8

Basal Low High

WG

D (

mg

min

-1 k

g-1

)

Preop Postop

*

Nygren et al, Clin Sci 1996

P-Insulin 10 30 65 µU/ml

Clamp

Page 18: PERIOperative pathophysiology and the objectives behind

Insulin resistance muscle

• Reduced glucose uptake

• Reduced glycogen storage

• Increased protein catabolism

Page 19: PERIOperative pathophysiology and the objectives behind

Insulin resistance muscle

• Reduced glucose uptake

• Reduced glycogen storage

• Increased protein catabolism

Lean body mass

Muscle function

Mobilisation

Energy supply

Page 20: PERIOperative pathophysiology and the objectives behind

0

5

10

15

20

25

30

g N

/ d

ay

12 h fasting

abdominal surgery

trauma burns sepsis

38 g protein

180 g lean body mass

Stress and protein loss

Page 21: PERIOperative pathophysiology and the objectives behind

Postoperative Catabolism

g weight lost

Fat Protein WaterHill et al. WJS. 1993

1400g

600g

1000g

Page 22: PERIOperative pathophysiology and the objectives behind

minor surgery 40 g

gastrointestinal tract surgery 100-150 g

sepsis 200 g

burns 300 g

1 g of nitrogen is 30 g hydrated lean tissue

1.2 kg

3 – 4.5 kg

6 kg

9 kg

Nitrogen loss

Page 23: PERIOperative pathophysiology and the objectives behind

Carli F, Schricker T, Metabolism, 2001

Page 24: PERIOperative pathophysiology and the objectives behind

Influence of body composition profile on outcomes following colorectal cancer surgery

Br J Surg 2016

• 805 patients for colorectal cancer surgery • Lumbar skeletal muscle index (LSMI), visceral

adipose tissue (VAT by analysis of CT images). • Myosteatosis associated with prolonged LOS • Muscle depletion independent risk for

complications and long LOS • Myopenia is an independent prognostic effect on

cancer survival for patients with colorectal cancer.

Page 25: PERIOperative pathophysiology and the objectives behind

32% returned to baseline at 2 months

Surgery

Loss of functional capacity after surgery for colorectal cancer (chao L, Surg Endosc 2013)

Page 26: PERIOperative pathophysiology and the objectives behind

Impact of insulin resistance on recovery

Page 27: PERIOperative pathophysiology and the objectives behind

HbA1c, Glucose control and postop complications

Gustafsson et al, BJS 2012

% o

f patients

Page 28: PERIOperative pathophysiology and the objectives behind

Postoperative insulin resistance increase the risk for complications

The ORs were adjusted for potential confounders

Complication OR for every decrease by 1 mg/kg/min

(Insulin sensitivity)

P value

Death 2.33 (0.94-5.78) 0.067

Major complication 2.23 (1.30-3.85) 0.004

Severe infection 4.98 (1.48-16.8) 0.010

Minor infection 1.97 (1.27-3.06) 0.003

Sato et al, JCEM 2010; 95: 4338-44

273 patients open cardiac surgery, insulin sensitivity determined at the end of op

Page 29: PERIOperative pathophysiology and the objectives behind

Operative Day glucose & outcomes

Jackson et al, JACS 2013

Colorectal cancer patients, n= 7,576

Glucose level Outcome Odds ratio (95% CI)

p value

Moderate (161-200 mg/dl) (8.9-11.1 mmol/l)

Surgical site infection

1.44 (1.10-1.87)

<0.01

Pneumonia 1.37 (1.00-1.87)

<0.05

Severe (>200mg/dl) (>11.1 mmol/l)

Pneumonia 1.55 (1.10-2.18)

<0.01

Re operation 1.37 (1.02-1.87)

<0.05

Page 30: PERIOperative pathophysiology and the objectives behind

Increasing hyperglycemia greater risk & longer stay

Kiran et al, Ann Surg 258; 2013

Reoperation

Length of stay

Page 31: PERIOperative pathophysiology and the objectives behind

Bagri H, Carli F, Anesthesiology

Development of Diabetes

Page 32: PERIOperative pathophysiology and the objectives behind

CJA, 2014

High rate of preoperative HbA1C in non diabetic colorectal patients

Page 33: PERIOperative pathophysiology and the objectives behind

Before Surgery

5.6

5.9

After Surgery

5.4

4.1

IS

IR

mc/kg/h

Page 34: PERIOperative pathophysiology and the objectives behind

Patients at risk of development of IR

• Elderly

• Cancer

• Frail

• Obese

• Depressed

Bagry H, Carli F, Anesthesiolooy 2008

Page 35: PERIOperative pathophysiology and the objectives behind

Perioperative Insulin Resistance

Physical status and exercise

Protein intake

Anti anxiety/depression

strategies

MIS

Glycemic control Medical optimization

Enhanced Recovery Program

Good pain control

Strategies to Impact on Insulin Resistance

Page 36: PERIOperative pathophysiology and the objectives behind

Gillis C, Carli F, Anesthesiology 2015

Page 37: PERIOperative pathophysiology and the objectives behind

The effects of a 2 week modified high intensity interval training program on the homeostatic model of insulin resistance (HOMA-IR) in adults with type 2 diabetes

J Sports Med Phys Fitness. 2014

• 6 individualized training sessions of HIT (4x30 seconds at 100% of estimated maximum workload followed by 4 minutes of active rest) over 2 weeks

• HOMA-IR calculated from fasting glucose/fasting insulin

• Decreased all parameters of glucose

• Better glucose utilization

Page 38: PERIOperative pathophysiology and the objectives behind

The effects of high-intensity interval (HIT) training on glucose regulation and insulin resistance: a meta-analysis

Obes Rev, 2015

• Fifty Studies, 250 pts

• > 2 weeks supervised HIT, 90% VO2 peak

• Decreased fasting glucose

• Decreased fasting insulin

• Better insulin sensitivity

• Average body fat loss of 1.3 kg

Page 39: PERIOperative pathophysiology and the objectives behind

0

0,02

0,04

0,06

0,08

0,1

0,12

0,14

0 10 20 30 40 50

a

b b

c

c

Increase in muscle protein synthesis following exercise with whey proteins, increased insulin

sensitivity

Mu

scle

FSR

(%

/h)

Dietary Protein (g)

Burke LM. Med Sci Sports Exerc. 2012;44(10):1968-77

Page 40: PERIOperative pathophysiology and the objectives behind

Pre Post0,0

2,5

3,0

3,5

4,0

Le

g M

us

cle

Str

en

gth

(k

g/k

g L

BM

) Casein

Immunocal

10 % Difference

99 elderly subjects ingested Immunocal (20g/day) or casein

(20g/day) for 135 days in combination with resistance training

3 times/week

Placebo

Page 41: PERIOperative pathophysiology and the objectives behind
Page 42: PERIOperative pathophysiology and the objectives behind

• Hepatectomy

• BG treated (6-8 mmol/l) vs BG control > 8mmol/l

• Hyperinsulinemic normoglycemic clamp before and after surgery to measure insulin resistance

Clinical Nutrition 2012

Page 43: PERIOperative pathophysiology and the objectives behind

Clinical Nutrition 2012

Keeping the B S <8mmol/l with insulin impacts on postop insulin resistance

Page 44: PERIOperative pathophysiology and the objectives behind

• 1284 diabetic patients

• Received metformin within 8-24 h of surgery

• Comparison with non-metformin therapy

• Propensity score analysis

Page 45: PERIOperative pathophysiology and the objectives behind

Metformin and recovery

Page 46: PERIOperative pathophysiology and the objectives behind

Take home message

• Metabolic response to surgery remains the pivotal concept which guides clinicians to identify therapeutic modalities

• Insulin resistance appears to be an important pathogenic mechanism which impacts on outcomes beyond LOS.

• We should continue to focus on physiology to explain other possible mechanisms which control surgical metabolism and recovery

Page 47: PERIOperative pathophysiology and the objectives behind
Page 48: PERIOperative pathophysiology and the objectives behind

Thank you